Clinical Report: ZEISS Unveils Cataract-Only EVA NEXUS
Overview
ZEISS Medical Technology has announced a new cataract-only configuration of its DORC EVA NEXUS surgical system. The system features advanced technologies.
Background
Cataract surgery is a common procedure that requires precision and efficiency. The introduction of specialized surgical systems, such as the DORC EVA NEXUS, reflects advancements in ophthalmic technology.
Data Highlights
No numerical or trial data provided in the source material.
Key Findings
- The DORC EVA NEXUS cataract configuration includes a cataract grade selection feature with up to four programmable presets.
- It utilizes VacuFlow VTi fluidics technology for improved flow and vacuum during procedures.
- SMART IOP technology helps maintain constant intraocular pressure.
- The system offers a customizable wireless Dual Linear footswitch for independent control of aspiration and ultrasound.
Clinical Implications
The DORC EVA NEXUS system is designed to support cataract surgeons during surgery.
Conclusion
The cataract-only EVA NEXUS by ZEISS is a new development in ophthalmic surgical technology.
Related Resources & Content
- Ophthalmology Management, 2026 -- Zeiss Introduces Cataract-Only Eva Nexus Surgical System Recommendations
- Glaucoma Physician, 2022 -- DORC Launches Eva Nexus Multipurpose Ophthalmic Surgery System
- European Society of Cataract and Refractive Surgeons Guideline for Cataract Surgery
- Glaucoma Physician — DORC Launches Eva Nexus Multipurpose Ophthalmic Surgery System
- retinal physician — EVA in Combination with 1.8 mm MICS and Nano Laserphaco Surgery
- ESCRS:44th Congress of the ESCRS
- Title: European Society of Cataract and Refractive Surgeons Guideline for Cataract Surgery
- Overview | Cataracts in adults: management | Guidance | NICE
- Evidence and intelligence considered in this review | Evidence | Cataracts in adults: management | Guidance | NICE
- Femtosecond laser-assisted cataract surgery versus conventional phacoemulsification cataract surgery: a meta-analysis of randomized controlled trials.
- Intracameral medications in cataract surgery - PubMed
- Active-fluidics versus gravity-fluidics in uncomplicated cataract surgery: using optical coherence tomography angiography to estimate early changes in macular and optic disc microcirculation | Graefe's Archive for Clinical and Experimental Ophthalmology | Springer Nature Link
- Comparison of Post-Operative Outcomes between IOP-20 and IOP-50 in Phacoemulsification with Active Fluidics System: Randomized Single Blinded Trial - PMC
- Active fluidics at lower intraocular pressure reduces intraoperative discomfort during phacoemulsification: a propensity score-matched cohort study - PubMed
Based on findings from:
ZEISS Unveils Cataract-Only EVA NEXUS
The Ophthalmologist, 2026.
https://theophthalmologist.com/issues/2026/articles/september/zeiss-unveils-cataract-only-eva-nexus/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
